Search

everythinglearnresearchcommunity

for

Search:↓

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Interferon α‐2b can temporarily reduce hepatitis C virus and normalize liver enzyme levels.

Prednisone reduces organ mast cell infiltration but does not alter the abnormal appearance of mast cells in systemic mastocytosis.

Brevilin-A is a safe and effective treatment for mild to moderate alopecia areata in children.

Ruxolitinib cream may help treat severe hair loss in children.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

The treatment was not recommended due to limited effectiveness and significant side effects.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

A multi-drug treatment can effectively clear extensive calcinosis in juvenile dermatomyositis.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

A reliable method was developed to measure gemcitabine and olaparib in pancreatic tissue, aiding pancreatic cancer treatment.

Dexamethasone oral mini-pulse therapy effectively treats severe alopecia areata when JAK inhibitors can't be used.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Most children with skin inflammation taking methotrexate had lab abnormalities, but liver issues often improved without changing the medication dose.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Cell therapy is advancing with stem cell transplants and genetically modified cells improving treatment for diseases like cancer and autoimmune disorders.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Photobiomodulation Therapy (PBMT) is recommended as a more inclusive term and shows potential benefits in various treatments.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

KIT's role in skin cells is not entirely independent, as other cells can influence its function.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Combining ciclosporin and simvastatin can cause severe kidney damage.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.